Search

Search Constraints

You searched for: Author/Creator Werner, Theresa

Search Results

1. Combating subclonal evolution of resistant cancer phenotypes. Issue 1 (December 2017)

2. Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018). Issue 1 (13th February 2019)

3. EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material. (4th December 2022)

5. Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery. (21st May 2019)

8. TP024/#446 Upgrade: phase 1 combination trial of the NAPI2B-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UPRI; XMT-1536) in patients with ovarian cancer. (4th December 2022)